Ayrton Capital’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $193K | Sell |
92,087
-184,905
| -67% | -$388K | 1.31% | 12 |
|
|
2023
Q2 | $792K | Sell |
276,992
-753,538
| -73% | -$2.16M | 4.95% | 7 |
|
|
2023
Q1 | $3M | Sell |
1,030,530
-2,600
| -0.3% | -$7.57K | 10.77% | 2 |
|
|
2022
Q4 | $3.03M | Hold |
1,033,130
| – | – | 8.27% | 2 |
|
|
2022
Q3 | $2.48M | Buy |
1,033,130
+880,000
| +575% | +$2.11M | 4.35% | 5 |
|
|
2022
Q2 | $343K | Hold |
153,130
| – | – | 0.56% | 43 |
|
|
2022
Q1 | $352K | Hold |
153,130
| – | – | 0.46% | 53 |
|
|
2021
Q4 | $383K | Buy |
+153,130
| New | +$383K | 0.36% | 59 |
|